Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Incruse Ellipta 55micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) |
| BNF code | 0301020T0BBAAAA |
| Virtual Medicinal Product | Umeclidinium bromide 65micrograms/dose dry powder inhaler |
| Name | Incruse Ellipta 55micrograms/dose dry powder inhaler |
| Supplier | GlaxoSmithKline UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✓ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Inhalation |
| Actual Medicinal Product Packs | |
| Incruse Ellipta 55micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) 30 dose | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.